Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment

Overview

Journal Curr Protoc Toxicol

Specialty Toxicology

Date 2012 Oct 10

PMID 23045101

Authors

Michael I Luster

Dori R Germolec

Christine G Parks

Laura Blaciforti

Michael Kashon

Robert Luebke

Affiliations

Soon will be listed here.

Abstract

This overview unit discusses the relationship between immunosuppression, a potential consequence of immunotoxicity, and disease progression. It also discusses other factors, such as stress and age, that affect disease susceptibility. These factors play an important role in risk assessment for exposures to environmental factors.

References

Sheridan J, Tutschka P, Sedmak D, Copelan E . Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation. Blood. 1990; 75(7):1583-6. View

Wilson S, McCay J, Butterworth L, MUNSON A, White Jr K . Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice. Toxicol Appl Pharmacol. 2001; 177(3):208-18. DOI: 10.1006/taap.2001.9298. View

Schultz C, Reiss I, Bucsky P, Gopel W, Gembruch U, Ziesenitz S . Maturational changes of lymphocyte surface antigens in human blood: comparison between fetuses, neonates and adults. Biol Neonate. 2000; 78(2):77-82. DOI: 10.1159/000014253. View

Thomas P, Yates D, Barnes P . Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med. 1995; 152(1):76-80. DOI: 10.1164/ajrccm.152.1.7599866. View

Lesourd B . Immune response during disease and recovery in the elderly. Proc Nutr Soc. 1999; 58(1):85-98. DOI: 10.1079/pns19990013. View

Cohen S . Psychological stress and susceptibility to upper respiratory infections. Am J Respir Crit Care Med. 1995; 152(4 Pt 2):S53-8. DOI: 10.1164/ajrccm/152.4_Pt_2.S53. View

Yucesoy B, Vallyathan V, Landsittel D, Sharp D, Weston A, Burleson G . Association of tumor necrosis factor-alpha and interleukin-1 gene polymorphisms with silicosis. Toxicol Appl Pharmacol. 2001; 172(1):75-82. DOI: 10.1006/taap.2001.9124. View

Germolec D . Sensitivity and predictivity in immunotoxicity testing: immune endpoints and disease resistance. Toxicol Lett. 2004; 149(1-3):109-14. DOI: 10.1016/j.toxlet.2003.12.025. View

Gavazzi G, Krause K . Ageing and infection. Lancet Infect Dis. 2002; 2(11):659-66. DOI: 10.1016/s1473-3099(02)00437-1. View

10.

Hoyert D, Arias E, Smith B, MURPHY S, Kochanek K . Deaths: final data for 1999. Natl Vital Stat Rep. 2001; 49(8):1-113. View

11.

Burns E, Goodwin J . Immunodeficiency of aging. Drugs Aging. 1997; 11(5):374-97. DOI: 10.2165/00002512-199711050-00005. View

12.

Voccia I, Blakley B, Brousseau P, Fournier M . Immunotoxicity of pesticides: a review. Toxicol Ind Health. 1999; 15(1-2):119-32. DOI: 10.1177/074823379901500110. View

13.

Anderson R . Deaths: leading causes for 2000. Natl Vital Stat Rep. 2002; 50(16):1-85. View

14.

Cohen S, Tyrrell D, Smith A . Psychological stress and susceptibility to the common cold. N Engl J Med. 1991; 325(9):606-12. DOI: 10.1056/NEJM199108293250903. View

15.

Sleijffers A, Yucesoy B, Kashon M, Garssen J, de Gruijl F, Boland G . Cytokine polymorphisms play a role in susceptibility to ultraviolet B-induced modulation of immune responses after hepatitis B vaccination. J Immunol. 2003; 170(6):3423-8. DOI: 10.4049/jimmunol.170.6.3423. View

16.

Wilson C . Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr. 1986; 108(1):1-12. DOI: 10.1016/s0022-3476(86)80761-2. View

17.

OCHS L, Shu X, Miller J, Enright H, Wagner J, Filipovich A . Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood. 1995; 86(10):3979-86. View

18.

Storek J, Gooley T, Witherspoon R, Sullivan K, Storb R . Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol. 1997; 54(2):131-8. DOI: 10.1002/(sici)1096-8652(199702)54:2<131::aid-ajh6>3.0.co;2-y. View

19.

Penn I . Post-transplant malignancy: the role of immunosuppression. Drug Saf. 2000; 23(2):101-13. DOI: 10.2165/00002018-200023020-00002. View

20.

Esterling B, Antoni M, Kumar M, Schneiderman N . Defensiveness, trait anxiety, and Epstein-Barr viral capsid antigen antibody titers in healthy college students. Health Psychol. 1993; 12(2):132-9. DOI: 10.1037//0278-6133.12.2.132. View